Sponsor or institution
Clinical trials and research at Umoja Biopharma
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Umoja Biopharma that are recruiting, at sites in 2 countries (most in United States (2), Australia (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
UB-VV400 with rapamycin in relapsed/refractory B-cell lymphomas
A phase 1/2 trial tests UB-VV400 plus rapamycin in adults with relapsed or refractory B-cell lymphomas to see if it is safe and shows anti-tumor activity.
-
Testing UB-VV111 with and without Rapamycin for B-cell cancers
This study is testing a new treatment called UB-VV111, with and without another drug called rapamycin, to see if it can help people with certain types of B-cell cancers that haven't responded to other treatments.
Quick answers
How many clinical trials run by Umoja Biopharma are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.